---
title: ACS Dobfar vs WuXi Vaccines
slug_a: acs-dobfar
slug_b: wuxivaccines
site: cdmo
review_signal_gate: closed
canonical_path: /compare/acs-dobfar/wuxivaccines
---

# ACS Dobfar vs WuXi Vaccines

Side-by-side profile data from each company listing on this directory.

## ACS Dobfar

- Profile: [/companies/acs-dobfar](/companies/acs-dobfar)

ACS Dobfar — Italian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.

Services: 8. Modalities: 2. Indications: 1. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (8).

### Services

- API Synthesis & Manufacturing
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Stability Testing & Storage
- Extractables & Leachables Studies

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian

## WuXi Vaccines

- Profile: [/companies/wuxivaccines](/companies/wuxivaccines)

WuXi Vaccines — Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.

Services: 11. Modalities: 4. Indications: 1. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vaccine Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector